耐多药结核病治疗的最新趋势综述

Y. Himasree, K. Sukanya, K. Bhavyasri, K. Amrutha, Kothandam Hariprasath
{"title":"耐多药结核病治疗的最新趋势综述","authors":"Y. Himasree, K. Sukanya, K. Bhavyasri, K. Amrutha, Kothandam Hariprasath","doi":"10.4172/2161-1068.1000250","DOIUrl":null,"url":null,"abstract":"Drug resistance is reduction in effectiveness of an anti-microbial agents used in inhibiting the microorganisms or curing a disease. Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance by not responding to Isoniazid and Rifampicin the two most powerful anti-TB agents. The complications of drug resistance in TB elevates due to some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. \nProper diagnosis of the disease and switching to modified drug therapy may improve the treatment outcome. The drug treatment involves usage of combination of drugs Isoniazid, Rifampicin, Ethambutol along with other antimicrobial agents, and nutritional therapy, immunotherapy. In this review we discussed about the occurrence, treatment of multi drug resistance tuberculosis along with drugs under trials and nutritional requirements.","PeriodicalId":74235,"journal":{"name":"Mycobacterial diseases : tuberculosis & leprosy","volume":"7 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2161-1068.1000250","citationCount":"1","resultStr":"{\"title\":\"Recent Trends in Treatment of Multidrug Resistant-Tuberculosis-A Review\",\"authors\":\"Y. Himasree, K. Sukanya, K. Bhavyasri, K. Amrutha, Kothandam Hariprasath\",\"doi\":\"10.4172/2161-1068.1000250\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drug resistance is reduction in effectiveness of an anti-microbial agents used in inhibiting the microorganisms or curing a disease. Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance by not responding to Isoniazid and Rifampicin the two most powerful anti-TB agents. The complications of drug resistance in TB elevates due to some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. \\nProper diagnosis of the disease and switching to modified drug therapy may improve the treatment outcome. The drug treatment involves usage of combination of drugs Isoniazid, Rifampicin, Ethambutol along with other antimicrobial agents, and nutritional therapy, immunotherapy. In this review we discussed about the occurrence, treatment of multi drug resistance tuberculosis along with drugs under trials and nutritional requirements.\",\"PeriodicalId\":74235,\"journal\":{\"name\":\"Mycobacterial diseases : tuberculosis & leprosy\",\"volume\":\"7 1\",\"pages\":\"1-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2161-1068.1000250\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mycobacterial diseases : tuberculosis & leprosy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2161-1068.1000250\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycobacterial diseases : tuberculosis & leprosy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-1068.1000250","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

耐药性是用于抑制微生物或治疗疾病的抗微生物剂的有效性降低。结核分枝杆菌对异烟肼和利福平这两种最有效的抗结核药物无反应,可获得多重耐药。由于一些风险因素,如治疗依从性不足,患者不遵守治疗,结核病耐药并发症会增加。正确诊断疾病并改用改良药物治疗可改善治疗结果。药物治疗包括异烟肼、利福平、乙胺丁醇与其他抗菌剂联合使用,以及营养疗法、免疫疗法。本文综述了耐多药结核病的发生、治疗、试验药物和营养需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Recent Trends in Treatment of Multidrug Resistant-Tuberculosis-A Review
Drug resistance is reduction in effectiveness of an anti-microbial agents used in inhibiting the microorganisms or curing a disease. Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance by not responding to Isoniazid and Rifampicin the two most powerful anti-TB agents. The complications of drug resistance in TB elevates due to some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. Proper diagnosis of the disease and switching to modified drug therapy may improve the treatment outcome. The drug treatment involves usage of combination of drugs Isoniazid, Rifampicin, Ethambutol along with other antimicrobial agents, and nutritional therapy, immunotherapy. In this review we discussed about the occurrence, treatment of multi drug resistance tuberculosis along with drugs under trials and nutritional requirements.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Study of white rot fungi for the production of laccase and its multifold application To Study The Effect of Pesticide Resistant Azotobacter spp. For The Production of Biofertilizer Inbred Mouse Strain Susceptibility to Tuberculosis Infection Vary with Phenotype, the Dose of Infection, Obesity and Composition of the Intestinal Microbiome Recombinant antigens and synthetic peptides to characterize Mycobacterium tuberculosis proteins for immunological reactivity The potential of delayed type hypersensitivity-inducing Mycobacterium tuberculosis-specific antigens in the diagnosis of tuberculosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1